Previous 10 | Next 10 |
Glenview Capital Management’s 13F portfolio value increased from $4.36B to $5.90B this quarter. The number of positions increased from 54 to 63. They increased AmerisourceBergen, Facebook, Alphabet, and Baxter International while reducing Laboratory Corp. and dropping Expedia G...
Regional bank consolidation continues with three new bank deals announced last week. Extended Stay America catches a higher bid. Chamath Palihapitiya files for four new biotech-focused SPACs. For further details see: Merger Arbitrage Mondays: Extended Stay America Receiv...
Strengthening Board of Directors with Expertise in Innovative Product Launches NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiat...
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma ® , PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s s...
PRA Health Sciences (PRAH): Q1 Non-GAAP EPS of $1.35 beats by $0.02; GAAP EPS of $0.86 misses by $0.08.Revenue of $933.8M (+19.2% Y/Y) beats by $70.88M.Press Release For further details see: PRA Health Sciences EPS beats by $0.02, beats on revenue
Net new business of $797.2 million; representing growth of 31.8%; Net book-to-bill of 1.24 excluding reimbursement revenue Net new business of $1,154.4 million; representing growth of 20.8%; Net book-to-bill of 1.33 including reimbursement revenue $933.8 million of total...
Shares of PRA Health Sciences Inc. (NASDAQ:PRAH) traded at a new 52-week high today of $165.86. So far today approximately 147,000 shares have been exchanged, as compared to an average 30-day volume of 876,000 shares. PRA Health Sciences is a global contract research organization that pr...
PRA Health Solutions (PRAH) is now offering post-marketing services, such as post-authorization safety studies, for COVID-19 vaccines and therapies.The company's services can detect, assess, minimize, and prevent adverse effects or other drug-related risks.Since the pandemic began, PRA has la...
RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including post-authorization safety studies (PASS) de...
Shares of PRA Health Sciences Inc. (NASDAQ:PRAH) traded at a new 52-week high today of $163.66. Approximately 147,000 shares have changed hands today, as compared to an average 30-day volume of 875,000 shares. PRA Health Sciences Inc. (NASDAQ:PRAH) is currently priced 0.6% above its aver...
News, Short Squeeze, Breakout and More Instantly...
PRA Health Sciences Inc. Company Name:
PRAH Stock Symbol:
NASDAQ Market:
PRA Health Sciences Inc. Website:
DT Midstream Set to Join S&P MidCap 400 DT Midstream Set to Join S&P MidCap 400 PR Newswire NEW YORK , June 28, 2021 /PRNewswire/ -- DT Midstream Inc. (NYSE: DTM) will replace PRA Health Sciences Inc. (NASD: PRAH) in the S&P MidCap 400 effective p...
Through this strategic partnership, the network aims to reach more than 25,000 physicians and 40 million patients, accelerating trial recruitment and enrollment efforts and expanding patients’ access to clinical research Veradigm®, a leading provider of healthcar...
Strengthening Board of Directors with Expertise in Innovative Product Launches NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiat...